Results 11 to 20 of about 53,571 (225)

Review of oritavancin for the treatment of acute bacterial skin and skin structure infections [PDF]

open access: yesFarmacia Hospitalaria, 2018
Objective: To assess critically oritavancin, a second-generation lipoglycopeptide, for the treatment of Acute Bacterial Skin and Skin Structure Infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus ...
Ana Alejandra García Robles   +4 more
doaj   +4 more sources

Acute bacterial skin and skin structure infections: current perspective

open access: yesIndian Journal of Dermatology, 2011
A skin and skin structure infection is a bacterial infection of skin and associated tissues. It may be complicated skin and skin structure infection or uncomplicated skin and skin structure infection. Recently, the Food and Drug Administration has called
Megha Shah, Hetal D Shah
doaj   +2 more sources

Hospital-acquired Skin and Skin-structure Infection in COVID-19 Infected Patient with Prolonged Hospitalization [PDF]

open access: yesActa Medica Indonesiana, 2021
Acute bacterial skin and skin-structure infections (ABSSSI) is defined in 2013 by the US Food and Drug Administration as a bacterial cellulitis/erysipelas, major skin abscesses, and wound infections.
Erni Juwita Nelwan   +3 more
doaj   +4 more sources

Opportunities for antimicrobial stewardship in patients with acute bacterial skin and skin structure infections who are unsuitable for beta-lactam antibiotics: a multicenter prospective observational study [PDF]

open access: yesTherapeutic Advances in Infectious Disease, 2019
Purpose: The objective of this prospective, observational study was to describe the treatment, severity assessment and healthcare resources required for management of patients with acute bacterial skin and skin structure infections who were unsuitable ...
Jonathan A.T. Sandoe   +8 more
doaj   +2 more sources

Tackling Extended Hospital Stays in Patients with Acute Bacterial Skin and Skin Structure Infections [PDF]

open access: yesEuropean Medical Journal, 2022
Hospitalisation rates for acute bacterial skin and skin structure infection (ABSSSI) are rising and represent a large pharmacoeconomic burden as treatment may involve an extended number of days of antibiotic therapy. This article first aims to provide a
Gavin Barlow   +2 more
doaj   +2 more sources

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

open access: yesTherapeutics and Clinical Risk Management, 2016
Kimberly D Leuthner,1 Kristin A Buechler,1 David Kogan,1 Agafe Saguros,1 H Stephen Lee2 1Department of Pharmaceutical Services, University Medical Center of Southern Nevada, Las Vegas, NV, USA; 2Roseman University of Health Sciences College of Pharmacy,
Leuthner KD   +4 more
doaj   +1 more source

The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials

open access: yesInfection and Drug Resistance, 2019
Chih-Wei Chen,1,2 Shen-Peng Chang,3 Hui-Ting Huang,4 Hung-Jen Tang,5 Chih-Cheng Lai61Division of Neurosurgery, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan; 2Department of Occupational Safety and Health/Institute of Industrial Safety and
Chen CW   +4 more
doaj   +1 more source

A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections [PDF]

open access: yesInfectious Diseases and Therapy, 2020
Background We sought to determine the real-world incidence of and risk factors for vancomycin-associated acute kidney injury (V-AKI) in hospitalized adults with acute bacterial skin and skin structure infections (ABSSSI).
Sarah C. J. Jorgensen   +16 more
doaj   +3 more sources

Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection. [PDF]

open access: yesAntimicrob Agents Chemother, 2015
A systematic literature review and meta-analysis were conducted to estimate the antibacterial treatment effect for linezolid and ceftaroline to inform on the design of acute bacterial skin and skin structure infection (ABSSSI) noninferiority trials.
Cates JE   +3 more
europepmc   +2 more sources

Risk Factors for Bloodstream Infections Among an Urban Population with Skin and Soft Tissue Infections: A Retrospective Unmatched Case-Control Study

open access: yesInfectious Diseases and Therapy, 2018
Introduction The prevalence of acute bacterial skin and skin structure infections (ABSSSIs) continues to increase. Bloodstream infection (BSI) is a severe secondary complication of ABSSSI.
Michael J. Rybak   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy